Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells

Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells

Mammalian pluripotent stem cells (PSCs) represent an important venue for understanding basic principles regulating tissue-specific differentiation and discovering new tools that may facilitate clinical applications. Mechanisms that direct neural differentiation of PSCs involve growth factor signalin...

Full description

Bibliographic Details
Main Authors:	Yaping Sun, Zhiqiang Dong, Taihao Jin, Kean-Hooi Ang, Miller Huang, Kelly M Haston, Jisong Peng, Tao P Zhong, Steven Finkbeiner, William A Weiss, Michelle R Arkin, Lily Y Jan, Su Guo
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2013-09-01
Series:	eLife
Subjects:	chemical genetic small molecule tool cellular differentiation dopaminergic neuron pluripotent stem cell
Online Access:	https://elifesciences.org/articles/00508

Similar Items

Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside
by: Mengmeng Wang, et al.
Published: (2020-06-01)

Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells
by: Douglas A. Grow, et al.
Published: (2016-09-01)

Brainstem Organoids From Human Pluripotent Stem Cells
by: Nobuyuki Eura, et al.
Published: (2020-06-01)

Systemic administration of valproic acid and zonisamide promotes the survival and differentiation of induced pluripotent stem cell–derived dopaminergic neurons
by: Tatsuya eYoshikawa, et al.
Published: (2013-02-01)

Host-to-graft propagation of inoculated α-synuclein into transplanted human induced pluripotent stem cell-derived midbrain dopaminergic neurons
by: Serina Gima, et al.
Published: (2024-03-01)

Erratum: Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell–derived dopaminergic neurons.
by: Tatsuya eYoshikawa, et al.
Published: (2013-07-01)

Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells
by: Takeshi Kato, et al.
Published: (2023-09-01)

Assessment of Mitochondrial Gene Activity in Dopaminergic Neuron Cultures Derived from Induced Pluripotent Stem Cells Obtained from Parkinson's Disease Patients
by: Anna S. Vetchinova, et al.
Published: (2023-12-01)

Influence of N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine on the Expression of Neurotrophic Factors in Neuronal Differentiated Cultures of Human Induced Pluripotent Stem Cells under Conditions of Oxidative Stress
by: Ekaterina Novosadova, et al.
Published: (2022-01-01)

Experimental evidence of a limited impact of new-generation perfluoroalkyl substance C6O4 on differentiating human dopaminergic neurons from induced pluripotent stem cells
by: Andrea Di Nisio, et al.
Published: (2023-01-01)

From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
by: Yee Jie Yeap, et al.
Published: (2023-01-01)

Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells
by: Theo Stoddard-Bennett, et al.
Published: (2019-01-01)

Metabolic Profile Variations along the Differentiation of Human-Induced Pluripotent Stem Cells to Dopaminergic Neurons
by: Emma Veronica Carsana, et al.
Published: (2022-08-01)

Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
by: Hayato Fukusumi, et al.
Published: (2021-02-01)

Long-Term Evaluation of Intranigral Transplantation of Human iPSC-Derived Dopamine Neurons in a Parkinson’s Disease Mouse Model
by: Sébastien Brot, et al.
Published: (2022-05-01)

Neurotransplantation: the time has come?
by: Sergey N. Illarioshkin
Published: (2018-12-01)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01)

Central and Peripheral Nervous System Progenitors Derived from Human Pluripotent Stem Cells Reveal a Unique Temporal and Cell-Type Specific Expression of PMCAs
by: Muwan Chen, et al.
Published: (2018-02-01)

Natural Molecules From Chinese Herbs Protecting Against Parkinson’s Disease via Anti-oxidative Stress
by: Yaqi Ding, et al.
Published: (2018-08-01)

Direct conversion of human fibroblasts into dopaminergic neuron-like cells using small molecules and protein factors
by: Hua Qin, et al.
Published: (2020-11-01)

Enfermedad de Parkinson: actualización de estudios preclínicos con el uso de células troncales pluripotentes inducidas
by: V. Valadez-Barba, et al.
Published: (2023-11-01)

Morphochemical evaluation of neurotransplantation outcomes in experimental Parkinsonism
by: A. V. Stavrovskaya, et al.
Published: (2017-02-01)

Electrophysiological Quality Control of Human Dopaminergic Neurons: Are We Doing Enough?
by: Vincent Seutin
Published: (2021-08-01)

Toward Generating Subtype-Specific Mesencephalic Dopaminergic Neurons in vitro
by: Tiago Cardoso, et al.
Published: (2020-06-01)

Composite Coatings Based on Recombinant Spidroins and Peptides with Motifs of the Extracellular Matrix Proteins Enhance Neuronal Differentiation of Neural Precursor Cells Derived from Human Induced Pluripotent Stem Cells
by: Ekaterina V. Novosadova, et al.
Published: (2023-03-01)

Challenges involved in cell therapy for Parkinson’s disease using human pluripotent stem cells
by: Heechang Moon, et al.
Published: (2023-10-01)

Acquisition and maintenance of pluripotency are influenced by fibroblast growth factor, leukemia inhibitory factor, and 2i in bovine-induced pluripotent stem cells
by: Ramon Cesar Botigelli, et al.
Published: (2022-09-01)

A functional characterisation of retrorubral field dopaminergic neurons
by: Bryden, LA
Published: (2021)

Effects of different concentrations of dimethylsulfoxide on development of zebrafish embryos and dopamine neurons
by: GAN Jinfan, et al.
Published: (2019-08-01)

Chemical and Biological Molecules Involved in Differentiation, Maturation, and Survival of Dopaminergic Neurons in Health and Parkinson’s Disease: Physiological Aspects and Clinical Implications
by: Giulia Gaggi, et al.
Published: (2021-06-01)

Cell Therapy for Parkinson’s Disease
by: Surabhi Shastry, et al.
Published: (2023-11-01)

Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons
by: Paula Chlebanowska, et al.
Published: (2020-08-01)

A Monolayer System for the Efficient Generation of Motor Neuron Progenitors and Functional Motor Neurons from Human Pluripotent Stem Cells
by: Alessandro Cutarelli, et al.
Published: (2021-05-01)

Dextran sulfate prevents excess aggregation of human pluripotent stem cells in 3D culture by inhibiting ICAM1 expression coupled with down-regulating E-cadherin through activating the Wnt signaling pathway
by: Haibin Wu, et al.
Published: (2022-05-01)

Excessive Daytime Sleepiness in Parkinson’s Disease
by: Liu H, et al.
Published: (2022-09-01)

Human Mesenchymal Stromal Cells Unveil an Unexpected Differentiation Potential toward the Dopaminergic Neuronal Lineage
by: Giulia Gaggi, et al.
Published: (2020-09-01)

Varying Auxin Levels Induce Distinct Pluripotent States in Callus Cells
by: Jinwoo Shin, et al.
Published: (2018-11-01)

Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish
by: Lisa M. Barnhill, et al.
Published: (2020-07-01)

Current status of stem cell-derived therapies for Parkinson’s disease : from cell assessment and imaging modalities to clinical trials
by: Jang, Se Eun, et al.
Published: (2021)

Effect of citronellol on oxidative stress, neuroinflammation and autophagy pathways in an in vivo model of Parkinson's disease
by: Richard L. Jayaraj, et al.
Published: (2022-11-01)